Genetic Inheritance: How Traits Pass to Your Baby

• We each carry 46 chromosomes in 23 pairs, one of each pair from each parent. Which combination lands in a given egg or sperm is essentially random, which is why siblings differ.
• Single-gene conditions follow set patterns, dominant (one faulty copy is enough), recessive (both copies must be faulty), or X-linked (often affecting boys more).
• Thalassaemia and sickle cell disease are recessive and common in India. A simple, inexpensive blood test before pregnancy can tell you if you are a carrier.
• Most common conditions like diabetes and heart disease are multifactorial: many genes plus lifestyle. Family history raises risk but does not seal it.
• Consanguineous (blood-relative) couples have a modestly higher risk of recessive conditions, but most of their children are healthy and counselling, not avoidance, is the answer.
• Preconception genetic counselling and carrier screening are recommended for all Indian couples, not just those with a known family history.

Almost every cell in your body carries a nucleus, and inside it sits your genetic material packaged into 46 chromosomes arranged as 23 pairs. One member of each pair comes from your mother through her egg, the other from your father through his sperm. Twenty-two pairs are numbered autosomes (1 to 22); the 23rd pair is the sex chromosomes, XX in females and XY in males. Chromosomes are long molecules of DNA wound around protein scaffolds, and strung along them are thousands of genes, each a stretch of DNA that codes for a protein or a regulatory job.

When eggs and sperm form, a special cell division called meiosis halves the count so each gamete carries just 23 chromosomes, one of each pair. At fertilisation the two halves combine and the full set of 46 is restored in the embryo. Which member of each pair ends up in a particular egg or sperm is essentially random, so siblings who share the same parents still inherit different combinations and look and behave differently. There are millions of possible chromosome combinations in a single egg or sperm, and recombination during meiosis adds even more variety. This is exactly why predicting a child's traits is only ever partial.

Genes usually come in different versions called alleles. If you inherit two of the same allele you are homozygous; two different alleles make you heterozygous. How those alleles interact decides the trait. In dominant inheritance one copy of the dominant allele is enough to show the trait; in recessive inheritance both copies must be the recessive version. Some inheritance is more complex, involving many genes, environmental influences or special chromosomal effects.

The sex chromosomes deserve a special word. Mothers always pass an X. Fathers pass either an X (a girl) or a Y (a boy), so the father's contribution sets the baby's genetic sex. The X chromosome carries many genes, including some that cause disease when faulty; the smaller Y carries far fewer. Because males have only one X, X-linked conditions tend to affect boys more often and more severely, while girls can be unaffected carriers.

• Continue natural conception knowing each child has a 50 percent risk.
• Prenatal diagnosis by chorionic villus sampling at 11 to 13 weeks or Amniocentesis in India: When It's Needed, Risks, Results & NIPT at 15 to 20 weeks, with termination an option under India's MTP Act if the fetus is affected.
• Preimplantation genetic testing via IVF, where embryos are tested and only unaffected ones are transferred.
• Considering donor gametes where appropriate.

In autosomal recessive inheritance, both copies of a gene must be faulty for the condition to show. Most parents in this situation are heterozygous carriers: one normal copy and one faulty copy. Carriers are usually completely healthy because the single normal copy does the job. When both parents are carriers, each pregnancy has a 25 percent chance of an affected child, a 50 percent chance of a carrier child like the parents, and a 25 percent chance of a child with two normal copies. This is why recessive conditions so often appear out of the blue, in families with no known affected relatives.

The most important recessive conditions in India are the haemoglobinopathies, especially beta thalassaemia and sickle cell disease. A child who inherits two faulty beta-globin genes has beta thalassaemia major and needs lifelong blood transfusions and iron chelation, with poor survival without a bone marrow transplant. The thalassaemia carrier rate is roughly 3 to 4 percent across India and much higher in some communities, including Sindhis, Punjabis, Gujaratis, Bengalis and several others. Sickle cell disease is common in tribal populations across central and western India, with carrier rates reaching 10 to 20 percent in parts of Gujarat, Maharashtra, Odisha, Chhattisgarh and West Bengal. HbE is another recessive variant common in Bengali populations.

FOGSI and ICMR recommend that all couples planning a pregnancy be offered thalassaemia carrier screening, with sickle cell screening added in relevant communities. The test is a simple blood sample analysed for HbA2 by HPLC or capillary electrophoresis, widely available for roughly 500 to 1,500 rupees. If one partner screens positive, the other is tested. If both are carriers, counselling explains the 25 percent risk and the options, and prenatal diagnosis or preimplantation testing can follow. A wider genetic carrier screening panel can be offered to couples with extra risk factors.

Other recessive conditions include cystic fibrosis (less common in India than in the West but real), Wilson disease (a copper-handling disorder), Gaucher disease, Tay-Sachs disease and many rare metabolic disorders. Consanguinity raises the risk of recessive disorders because related parents share more genes, including disease-causing ones, so consanguineous couples especially benefit from detailed counselling and expanded carrier panels.

X-linked conditions are caused by genes on the X chromosome, and because females have two X chromosomes while males have one, the patterns differ between the sexes. In X-linked recessive conditions a boy with the faulty gene on his only X will be affected, since there is no second X to compensate. A girl with one faulty and one normal X is usually an unaffected carrier, because her normal X supplies enough function.

Classic X-linked recessive conditions include haemophilia A and B (clotting-factor bleeding disorders), Duchenne muscular dystrophy (progressive muscle weakness appearing in childhood, almost only in boys), red-green colour blindness (the commonest X-linked trait, affecting around 8 percent of men worldwide), and fragile X syndrome, the most common inherited cause of intellectual disability. Fragile X deserves a special mention because it is relatively common, can be silent in carrier females and needs a specific molecular test to detect.

The inheritance maths follows clear rules. If the mother is a carrier and the father is unaffected, each son has a 50 percent chance of being affected and each daughter a 50 percent chance of being a carrier. If the father is affected and the mother is not a carrier, all daughters become obligate carriers (they receive his X) and no sons are affected (they receive his Y), so there is no father-to-son transmission. A family pattern of affected males across generations, linked through unaffected mothers and never father to son, is the tell-tale sign.

Reproductive options mirror those for other single-gene conditions: natural conception with the risks understood, prenatal diagnosis, and preimplantation genetic testing for a known mutation. Where the specific gene is unknown but the family pattern is clear, selecting female embryos by preimplantation testing can avoid an affected son, but only for a recognised X-linked medical indication. India's PCPNDT Act bans sex selection and disclosure of fetal sex for social reasons, allowing it only for defined medical indications, so this must be done with careful counselling and full legal compliance.

Mitochondrial inheritance breaks the usual Mendelian rules. Mitochondria, the cell's energy factories, carry their own small circular DNA with 37 genes, separate from the chromosomes in the nucleus. They are inherited almost entirely from the mother through the egg, because sperm contribute essentially none. So a condition caused by a mitochondrial DNA mutation passes from an affected mother to all of her children, sons and daughters alike, but only her daughters can pass it on again. Affected fathers do not transmit mitochondrial disease.

Mitochondrial conditions can affect any organ but tend to strike tissues with high energy demand, the brain, muscles, heart and eyes. Examples include Leber hereditary optic neuropathy and MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes). Severity is hard to predict because the proportion of mutant mitochondria varies between tissues, a phenomenon called heteroplasmy.

Mitochondrial donation, sometimes called three-parent IVF, lets a mother with mitochondrial disease use her nuclear DNA with a donor's healthy mitochondria. It is approved in the UK and a few countries but is not available in India and remains globally controversial. For most affected Indian couples, counselling can cover the inheritance pattern, prenatal testing where feasible, and the option of egg donation, which supplies healthy donor mitochondria.

Other special patterns include genomic imprinting, where a gene behaves differently depending on whether it came from the mother or the father (relevant to Prader-Willi and Angelman syndromes), and trinucleotide repeat expansion disorders, where a repeated DNA stretch grows longer across generations and often causes earlier, more severe disease in successive generations (seen in Huntington disease, myotonic dystrophy and fragile X). Any couple with a relevant family history of these should see a specialist geneticist.

Most common conditions, diabetes, hypertension, heart disease, asthma, depression, obesity and many cancers, do not follow simple single-gene rules. They arise from the combined effect of many genes, often hundreds or thousands each contributing a little, interacting with diet, exercise, smoking, stress and other exposures. This is multifactorial or polygenic inheritance. Relatives of an affected person have a raised risk compared with the general population, but not in the clean 25 or 50 percent ratios of single-gene conditions.

Here family history shapes risk without dictating it. Having a parent or sibling with type 2 diabetes raises your risk roughly two to fourfold, yet weight, diet and activity strongly influence whether you actually develop it. The practical message: for most multifactorial conditions, lifestyle and family-history evaluation matter more than genetic testing. The exception is rare single-gene forms of common conditions, such as MODY (a monogenic diabetes) or familial hypercholesterolaemia, which can warrant targeted testing. Even a condition many think of as purely gynaecological, like endometriosis, has a hereditary component that is multifactorial rather than single-gene.

Several congenital conditions are also multifactorial, including most cleft lip and palate, many congenital heart defects, neural tube defects and clubfoot. They recur more often in affected families, but the recurrence risk is usually around 2 to 5 percent rather than 25 or 50 percent. Crucially, folic acid started before conception substantially lowers the risk of neural tube defects, even in families that have had a previously affected child, which is why preconception folic acid is emphasised so strongly.

Polygenic risk scores, which bundle the small effects of many variants into one risk estimate, are an active research area and increasingly sold commercially, but their clinical value is still being established and they need expert interpretation. For most couples, a good family-history review, basic preconception planning and lifestyle optimisation are far more useful than a polygenic score.

Consanguineous marriage, where partners are blood relatives such as first or second cousins, is common in several Indian communities, including some Muslim communities across the north and south, some Hindu communities in the south where cross-cousin marriage is traditional, and certain smaller groups. The proportion varies widely by community, region and urban or rural setting. Consanguinity often serves social and economic functions, keeping property within families, maintaining ties and easing dowry pressures.

The genetic consequence is that related partners share more genes, including the handful of disease-causing recessive alleles each of us carries. The chance that both partners carry the same recessive allele is higher, so the risk of a recessive disorder in the child rises. To put numbers on it: the background risk of a major birth defect in unrelated couples is about 3 percent. In first-cousin marriages this roughly doubles to about 5 to 6 percent. For second cousins the increase is smaller, and beyond that it is minimal.

The practical step is detailed preconception genetic counselling: a three-generation family history to surface any recessive conditions, expanded carrier screening for relevant disorders, a clear discussion of recurrence risks, and reproductive options. Many Indian genetic services have specific experience with consanguineous couples and provide non-judgemental, culturally sensitive guidance.

It is important to say clearly that consanguineous couples should not be told they cannot or should not have children. The added risk, while real, stays modest (about 5 to 6 percent versus 3 percent), and the great majority of their children are healthy. Counselling exists to give accurate information, identify specific testable risks and support informed choices. Couples should feel free to ask for genetic counselling at their first preconception or antenatal visit, with no shame attached to their relationship.

Genetic tests in pregnancy fall into two groups. Screening tests estimate the chance of a condition without a definitive answer and carry no risk to the pregnancy. Diagnostic tests give a definitive answer but carry a small miscarriage risk. Most pregnancies begin with screening, and diagnostic testing is offered if screening flags increased risk or there are other reasons such as a known family condition or advanced maternal age.

First-trimester combined screening pairs a maternal blood test (PAPP-A and free beta-hCG) with a nuchal translucency scan at 11 to 14 weeks, giving risk estimates for Down syndrome (trisomy 21), trisomy 18 and trisomy 13, with around 85 to 90 percent detection. Non-invasive prenatal testing (NIPT), which analyses fragments of fetal DNA in the mother's blood from about 10 weeks, has much higher detection (above 99 percent for trisomy 21) and is increasingly available in Indian metros for roughly 15,000 to 30,000 rupees.

Second-trimester options include the quadruple blood test and the fetal anomaly (TIFFA) scan at 18 to 22 weeks, a standard part of Indian antenatal care that checks the baby's structure for major malformations such as heart defects, neural tube defects and cleft lip and palate. Some findings can point to an underlying genetic condition and prompt further testing.

Diagnostic tests are chorionic villus sampling at 11 to 13 weeks and amniocentesis at 15 to 20 weeks. Both sample cells from the pregnancy to test for chromosomal abnormalities and, where a family mutation is known, for that specific mutation. In experienced centres the miscarriage risk is about 0.5 to 1 percent for CVS and about 0.5 percent for amniocentesis. Counselling beforehand is essential, and the woman's decision is hers to make. Termination is legal under India's MTP Act, with specific provisions for fetal anomaly up to 24 weeks in defined circumstances. After birth, the newborn screening heel-prick test catches several treatable inherited conditions early.

Access to genetic services in India has expanded a lot over the past two decades. The ICMR-supported centre at AIIMS New Delhi is a flagship national service for testing, counselling and research, with similar centres at PGI Chandigarh, CMC Vellore, NIMHANS Bengaluru and other regional AIIMS institutes serving large populations. Private networks such as Apollo, Fortis, Manipal and Max, and dedicated genetics labs including MedGenome, Strand Life Sciences and Mapmygenome, offer extensive testing and counselling.

For preconception screening, the core services are thalassaemia carrier screening (widely available), sickle cell screening in relevant communities, a family-history review with a clinical geneticist or trained counsellor, and expanded carrier panels for couples with specific risk factors such as consanguinity or unexplained family conditions. Private-sector costs vary: basic carrier screening may be 1,000 to 3,000 rupees per partner; expanded panels covering 100 to 300 conditions may be 10,000 to 40,000 rupees per partner; testing for a specific known family mutation may be 5,000 to 25,000 rupees.

In the public sector, basic genetic counselling and many tests are free or nominal through ICMR centres and government tertiary hospitals. Government schemes have widened coverage, including the Rashtriya Bal Swasthya Karyakram (RBSK) for children with congenital conditions and the National Programme for Prevention and Control of Haemoglobinopathies, which funds free thalassaemia screening in some states. State programmes in Gujarat, Maharashtra and Madhya Pradesh actively screen tribal populations for sickle cell disease.

For preimplantation genetic testing through IVF, several major fertility centres now serve couples at risk of single-gene disorders, chromosomal rearrangements or recurrent pregnancy loss. A cycle typically runs 200,000 to 400,000 rupees, with the genetic testing adding roughly 50,000 to 100,000 rupees. CVS and amniocentesis are widely available in tertiary maternal-fetal medicine units at relatively modest cost. The key takeaway is that genetic services are not only for advanced cases or affluent families; basic preconception counselling and carrier screening are recommended for all couples and within reach for most, ideally as part of a broader trying-to-conceive plan.

• You and your partner are blood relatives (first or second cousins, or more distant kin).
• Either family has a known inherited condition such as thalassaemia, sickle cell disease, haemophilia, muscular dystrophy or cystic fibrosis.
• There is a strong family history of breast, ovarian, colon cancer or premature heart disease, suggesting a hereditary syndrome.
• You have had two or more miscarriages, a stillbirth, or a previous child with a birth defect or developmental disorder.
• You belong to a community with a high carrier rate for thalassaemia or sickle cell disease.
• You will be 35 or older at delivery, or a screening test in pregnancy has come back high-risk.
• A pregnancy scan has shown a structural abnormality or soft marker that needs further evaluation.

• WHO – Genes and human disease / genomics in health
• ICMR – National Guidelines for Prevention and Control of Hemoglobinopathies (Thalassemia and Sickle Cell Disease) in India
• FOGSI (Federation of Obstetric and Gynaecological Societies of India) – Good Clinical Practice Recommendations
• NHS – Genetic and genomic testing / inherited conditions
• ACOG – Carrier Screening and Prenatal Genetic Testing